Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population.
Heredia D, Mas L, Cardona AF, Oyervides V, Motta Guerrero R, Galvez-Nino M, Lara-Mejía L, Aliaga-Macha C, Carracedo C, Varela-Santoyo E, Ramos-Ramírez M, Davila-Dupont D, Martínez J, Cruz-Rico G, Remon J, Arrieta O. Heredia D, et al. Among authors: lara mejia l. Lung Cancer. 2022 Dec;174:133-140. doi: 10.1016/j.lungcan.2022.11.002. Epub 2022 Nov 9. Lung Cancer. 2022. PMID: 36379126
Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer.
Arrieta O, Varela-Santoyo E, Cardona AF, Sánchez-Reyes R, Lara-Mejía L, Bassarmal SS, Valle-Bautista D, Corrales-Rodríguez L, Motola-Kuba D, Cabrera-Miranda L, Martín C. Arrieta O, et al. Clin Lung Cancer. 2021 Nov;22(6):510-522. doi: 10.1016/j.cllc.2021.03.014. Epub 2021 Mar 27. Clin Lung Cancer. 2021. PMID: 33947631
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer.
Avilés-Salas A, Flores-Estrada D, Lara-Mejía L, Catalán R, Cruz-Rico G, Orozco-Morales M, Heredia D, Bolaño-Guerra L, Soberanis-Piña PD, Varela-Santoyo E, Cardona AF, Arrieta O. Avilés-Salas A, et al. Among authors: lara mejia l. Thorac Cancer. 2022 Dec;13(23):3362-3373. doi: 10.1111/1759-7714.14695. Epub 2022 Oct 31. Thorac Cancer. 2022. PMID: 36317227 Free PMC article.
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer.
Avilés-Salas A, Díaz-García DA, Lara-Mejía L, Cardona AF, Orozco-Morales M, Catalán R, Hernández-Pedro NY, Rios-Garcia E, Ramos-Ramírez M, Arrieta O. Avilés-Salas A, et al. Among authors: lara mejia l. Curr Oncol. 2022 Dec 26;30(1):333-343. doi: 10.3390/curroncol30010027. Curr Oncol. 2022. PMID: 36661676 Free PMC article.
25 results